With the most recent release of data from the National Oncologic PET Registry (NOPR), researchers may have reached the moment of critical mass by confirming the effectiveness of positron emission tomography (PET) in the monitoring of tumor activity across a wide range of cancers.

Families coping with prostate cancer report improved quality of life from a structured support program integrated into the patient’s cancer management, according to a new study. The findings appear in the December 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.